Mutual Advisors LLC Increases Stake in GE HealthCare Technologies Inc. $GEHC

Mutual Advisors LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,589 shares of the company’s stock after purchasing an additional 199 shares during the quarter. Mutual Advisors LLC’s holdings in GE HealthCare Technologies were worth $511,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in GEHC. JPMorgan Chase & Co. boosted its stake in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth about $77,058,000. Eminence Capital LP boosted its stake in GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after purchasing an additional 507,101 shares during the period. Homestead Advisers Corp boosted its stake in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after purchasing an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board boosted its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research report on Thursday, September 18th. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. BTIG Research lifted their price target on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Finally, Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $74.05 on Monday. The stock has a market cap of $33.81 billion, a price-to-earnings ratio of 15.17, a P/E/G ratio of 2.83 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The stock’s 50-day moving average is $74.51 and its 200 day moving average is $72.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period last year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.